Form 8-K - Current report:
SEC Accession No. 0001104659-25-084845
Filing Date
2025-08-28
Accepted
2025-08-28 17:10:29
Documents
17
Period of Report
2025-08-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2524576d2_8k.htm   iXBRL 8-K 30584
2 EXHIBIT 1.1 tm2524576d2_ex1-1.htm EX-1.1 52768
3 EXHIBIT 4.1 tm2524576d2_ex4-1.htm EX-4.1 90531
4 EXHIBIT 5.1 tm2524576d2_ex5-1.htm EX-5.1 11510
5 EXHIBIT 10.1 tm2524576d2_ex10-1.htm EX-10.1 195401
9 GRAPHIC tm2524576d2_ex5-1img001.jpg GRAPHIC 2521
  Complete submission text file 0001104659-25-084845.txt   646826

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20250827.xsd EX-101.SCH 3005
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20250827_lab.xml EX-101.LAB 34239
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgtx-20250827_pre.xml EX-101.PRE 22352
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2524576d2_8k_htm.xml XML 3578
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40886 | Film No.: 251274632
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)